Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-25T09:11:00.007Z Has data issue: false hasContentIssue false
  • English
  • Français

A Double-Blind Gluten-Free/Gluten-Load Controlled Trial in a Secure Ward Population

Published online by Cambridge University Press:  29 January 2018

Dimitrios N. Vlissides ,
Andrzej Venulet  and
Frederick A. Jenner
Dimitrios N. Vlissides*
Affiliation:
University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF
Andrzej Venulet
Affiliation:
Department of Psychiatry, University of Sheffield (now at the Elizabeth Donkin Hospital, Port Elizabeth, Republic of South Africa)
Frederick A. Jenner
Affiliation:
Department of Psychiatry, University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

A double-blind control trial of gluten-free versus a gluten-containing diet was carried out in a ward of maximum security hospital: 24 patients were studied for 14 weeks. Most suffered from psychotic disorders, particularly schizophrenia. Various dimensions of behaviour were rated on the Psychotic In-Patient profile (PIP) at different stages. There were beneficial changes in the whole group of patients between pre-trial and gluten-free period in five dimensions of the PIP, maintained during the gluten challenge period; these changes could be attributed to the attention the patients received. Two patients improved during the gluten-free period and relapsed when the gluten diet was reintroduced.

Type
Papers
Information
The British Journal of Psychiatry , Volume 148 , Issue 4 , April 1986 , pp. 447 - 452
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ashkenazi, A., Krasilowsky, D., Levin, P., Idar, D., Kalian, M., Or, A., Ginat, Y. & Halperin, B. (1979) Immunologic reaction of psychotic patients to fraction of gluten. American Journal of Psychiatry, 136, 1306–1309.Google ScholarPubMed
Cooke, W. T., Fone, S. J., Cox, E. V., Meynell, M. Y. & Gaddie, R. (1963) Adult coeliac disease. Gut, 4, 279–291.CrossRefGoogle ScholarPubMed
Davis, C. (1978) Dietary pathogenesis of schizophrenia: an investigation into the effects of gluten. Nursing Times, 74, 2020–1.Google ScholarPubMed
Dean, G., Hanniffy, L., Stevens, F., Temperley, I., O'Brion, J. D., Scott, J. & Cahalane, A. F. (1975) Schizophrenia and coeliac disease. Journal of the Irish Medical Association, 68, 545–546.Google ScholarPubMed
Dohan, F. C. (1966a) Wartime changes in hospital admissions for schizophrenia: a comparison of admissions for schizophrenia and other psychoses in six countries during World War II. Acta Psychiatrica Scandinavica, 42, 1–22.CrossRefGoogle ScholarPubMed
Dohan, F. C. (1966b) Cereals and schizophrenia: data and hypothesis. Acta Psychiatrica Scandinavica, 42, 125–152.CrossRefGoogle Scholar
Dohan, F. C. (1980) Hypothesis: Genes and neuroactive peptides from food as cause of schizophrenia. In Neural Peptides and Neuronal Communication, (eds. Costa, E. & Trabucchi, M.). New York: Raven Press.Google Scholar
Dohan, F. C. (1981) Schizophrenia, coeliac disease, gluten antibodies and the importance of beta. Biological Psychiatry, 16, 1115–7.Google ScholarPubMed
Dohan, F. C. & Grasberger, J. C. (1973) Relapsed schizophrenics, earlier discharge from the hospital after cereal-free, milk-free diet. American Journal of Psychiatry, 130, 685–688.CrossRefGoogle ScholarPubMed
Dohan, F. C., Grasberger, J. C., Lowell, F. M., Johnston, H. T. & Arbegast, A. W. (1969) Relapsed schizophrenics: more rapid improvement on a milk- and cereal-free diet. British Journal of Psychiatry, 115, 595–596.CrossRefGoogle ScholarPubMed
Dohan, F. C., Harper, E. H., Clark, M. H., Rodrigue, R. B. & Zigas, V. (1984) Is schizophrenia rare if grain is rare? Biological Psychiatry, 19, 385–399.Google ScholarPubMed
Dohan, F. C., Martin, L., Grasberger, J. C., Boehme, D. & Cottrell, T. C. (1972) Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors. Biological Psychiatry, 5, 127–137.Google ScholarPubMed
Freed, W. J., Luchins, D. J., Gillin, J. C. & Wyatt, R. J. (1978) Wheat gluten impedes absorption of haloperidol. Biological Psychiatry, 13, 769–721.Google ScholarPubMed
Graff, H. & Handford, A. (1961) Coeliac syndrome in the case histories of five schizophrenics. Psychiatric Quarterly, 35, 306–313.CrossRefGoogle ScholarPubMed
Hekkens, W. Th. J. M. (1978) Antibodies to gliadin in serum of normals, coeliac patients and schizophrenics. In The Biological Basis of Schizophrenia (eds. Hemmings, G. & Hemmings, W. A.). Lancaster: MTP Press.Google Scholar
Hemmings, A. A. (1978) The entry into the brain of large molecules derived from dietary protein. Proceedings of the Royal Society of London, 200, 175–192.Google ScholarPubMed
Horrobin, D. F. (1979) Schizophrenia: reconciliation of the dopamine, prostaglandin and opioid concepts and the role of the pineal. Lancet, i. 529–531.CrossRefGoogle Scholar
Klee, W. A., Zioudrou, C. & Streaty, R. A. (1978) Exorphins, peptides with opioid activity isolated from wheat gluten and their possible role in the etiology of schizophrenia. In Endorphins in Mental Health Research, (ed. Usdin, E.). New York: MacMillan.Google Scholar
Lancet Editorial (1976) Gluten and schizophrenia. Lancet, i, 844.Google Scholar
Liu, X. (1980) Mental health work in Sichuan. British Journal of Psychiatry, 137, 371–376.CrossRefGoogle ScholarPubMed
Lorr, M. & Vester, N. D. (1968) Psychotic Inpatient Profile. Western Psychological Services (WPS). Minneapolis: University of Minnesota.Google Scholar
McGuffin, P., Gardiner, P. & Swinburne, L. M. (1981) Schizophrenia, coeliac disease and antibodies to food. Biological Psychiatry, 16, 281–285.Google ScholarPubMed
Mascord, I., Freed, D. & Durrant, B. (1978) Antibodies to foodstuff in schizophrenia. British Medical Journal, 1, 1351.CrossRefGoogle ScholarPubMed
Osborne, M., Clayton, J. W., Javaid, I. & Davis, J. M. (1982) Lack of effect of a gluten-free diet on neuroleptic blood levels in schizophrenic patients. Biological Psychiatry, 17, 627–629.Google ScholarPubMed
Potkin, S. G., Weinberger, D., Kleinman, J., Nasrallah, H., Luchins, D. Bigelow, L., Linnolia, M., Fischer, S. H., Bjornsson, T. D., Carman, J., Gillin, J. C. & Wyatt, R. J. (1981) Wheat challenge in schizophrenic patients. American Journal of Psychiatry, 138, 1208–1211.Google ScholarPubMed
Rice, J. R., Ham, C. H. & Gore, W. E. (1978) Another look at gluten in schizophrenia. American Journal of Psychiatry, 135, 1417–1418.Google Scholar
Ross-Smith, P. & Jenner, F. A. (1980) Die (gluten) and schizophrenia. Journal of Human Nutrition, 34, 107–112.Google Scholar
Singh, M. M. (1979) Schizophrenia: glutens and neuroleptics. Biological Psychiatry, 14, 853–855.Google Scholar
Singh, M. M. & Kay, S. R. (1976) Wheat gluten as a pathogenic factor in schizophrenia. Science, 191, 401–402.CrossRefGoogle ScholarPubMed
Stevens, F. M., Lloyd, R. S., Geraght, S. M. J., Reynolds, M. T. G., Sarsfield, M. J., McNicholl, B. Fottrell, P. F., Wright, R. & McCarthy, C. F. (1977) Schizophrenia and coeliac disease—the nature of relationship. Psychological Medicine, 7, 259–263.CrossRefGoogle ScholarPubMed
Storms, L. H., Jamie, M., Clopton, M. S. & Wright, C. (1982) Effects of gluten on schizophrenics. Archives of General Psychiatry, 39, 323–327.CrossRefGoogle ScholarPubMed
Wing, J. K., Cooper, J. E. & Sartorius, N. (1973) The Measurement and Classification of Psychiatric Symptoms. London: Cambridge University Press.Google Scholar
Zioudrou, C., Streaty, R. A. & Klee, W. A., (1979) Opioid peptides derived from food proteins. Journal of Biological Chemistry, 254, 2446–2449.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.